A new drug that could treat people with rheumatoid arthritis has been accepted for a biologic license application by the Food and Drug Administration. Tarrytown-based Regeneron Pharmaceuticals Inc. and Sanofi SA announced Jan. 8 that their drug sarilumab will be studied to see if it meets FDA requirements and can subsequently be marketed.
http://ift.tt/1SK6Zcp?
No comments:
Post a Comment